Adenosine labels and packages

Revision as of 18:23, 11 March 2014 by Ahmed Zaghw (talk | contribs)
Jump to navigation Jump to search
Adenosine
ADENOCARD®, ADENOSCAN® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Adenosine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Labels and Packages

[1]

References

  1. "ADENOCARD (ADENOSINE) SOLUTION [ASTELLAS PHARMA US, INC.]".

Adapted from the FDA Package Insert.